The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Routine Osteoporosis Screening in Men Proves Cost-Effective

Routine Osteoporosis Screening in Men Proves Cost-Effective

March 8, 2016 • By Shannon Aymes

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Routine osteoporosis screening in men is a good value and effective based on a cost-effectiveness model, researchers say.

You Might Also Like
  • RA Patients May Not Receive Needed Osteoporosis Screening & Treatment
  • Osteoporosis Screening Is Underutilized Despite Recommendations
  • BMI Feasible As Pre-Screening Tool for Osteoporosis in Women

“Osteoporosis is not just a disease for women. Osteoporosis affects many men (approximately 2 million in the U.S.), with significant morbidity, mortality, and costs that are projected to rise with the aging of the U.S. population,” Dr. Smita Nayak, of the Swedish Center for Research and Innovation at Swedish Health Services in Seattle, Wash., told Reuters Health by email.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Approximately one in four men will sustain a fragility fracture after age 50, and one in three men over the age of 65 who sustain a hip fracture die within one year after fracture,” Dr. Nayak noted.

According to the U.S. Preventive Services Task Force, there is insufficient evidence to assess the harms and benefits of osteoporosis screening in men.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Nayak and coauthor Dr. Susan Greenspan, of the University of Pittsburgh School of Medicine in Pennsylvania, sought to identify the most cost-effective and effective osteoporosis screening tool for men over age 50.

They developed a model to assess the cost-effectiveness of dual-energy x-ray absorptiometry (DXA), the Osteoporosis Self-Assessment Tool (OST), or a 10-year absolute fracture risk assessment for osteoporosis screening in men compared to no screening.

The models assumed screening at ages 50, 60, 70 or 80 years with five- or 10-year intervals. The model also accounted for treatment with bisphosphonates with a positive screen, osteoporotic fractures, need for a nursing home, treatment adverse events, and death.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

In 50-year-old men, the model predicted 23.6% without screening would develop a major osteoporotic fracture, most commonly of the hip.

The model predicted risks comparable with published risks, the authors said online Feb. 10 in the Journal of Bone and Mineral Research.

Using base-case analysis, they found that no screening was less effective and more costly than methods using OST or DXA. Further, screening initiated at age 50 and repeated every 10 years was associated with a $40,546 per quality-adjusted life-year (QALY) cost-effectiveness ratio and led to twice as many men receiving bisphosphonate treatment.

Fracture risk assessment screening started at age 50 and repeated every 10 years with an assumed willingness-to-pay of $50,000/QALY or $100,000/QALY was more effective in one-way sensitivity analysis. This was also found for DXA at age 50 and repeated every five years and fracture risk assessment at age 50 and repeated every five years.

“Our cost-effectiveness analysis of different osteoporosis screening tests, initiation ages, and repeat screening intervals for men aged 50 years and older found that many evaluated strategies are effective and cost-effective,” the researchers conclude.

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: Osteoporosis

You Might Also Like:
  • RA Patients May Not Receive Needed Osteoporosis Screening & Treatment
  • Osteoporosis Screening Is Underutilized Despite Recommendations
  • BMI Feasible As Pre-Screening Tool for Osteoporosis in Women
  • Reading Rheum

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.